[Current treatment of hepatitis B].
Sección de Aparato Digestivo, Hospital Universitarío de Valme, Sevilla.
E
E
Suárez García
M
M
Romero Gómez
L
L
Grande Santamaría
D015075:2-Aminopurine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D004261:DNA Replication / Q000502:physiology; D000077595:Famciclovir; D005544:Forecasting; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D006513:Hepatitis B e Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000187:drug effects / Q000502:physiology; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D019259:Lamivudine / Q000627:therapeutic use*; D063065:Organophosphonates; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D013997:Time Factors; D014779:Virus Replication / Q000502:physiology
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine; D015075:2-Aminopurine; C053001:adefovir; D000225:Adenine; D000077595:Famciclovir; C106812:adefovir dipivoxil; D011241:Prednisone